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1. Introduction  
Post-translational modifications of proteins are crucial because they may alter the physical 
and chemical properties, folding, distribution, stability, activity, and consequently the 
functions of the targets, some of which being involved into diseases. Recently, one of these 
post-translational modifications, deimination (also called citrullination), became of an 
increasing concern. It corresponds to the conversion of protein-bound arginine residues to 
citrulline residues in the presence of calcium ions (Figure 1). This modification dramatically 
alters the charge of residues from positive to neutral, probably resulting for the targets in 
loss of conformation, in aggregation ability, or in depolymerization tendency. 
Peptidylarginine deiminases (PADs, EC 3.5.3.15) have been found as the enzymes that 
catalyze deimination (Rogers and Taylor, 1977; Sugawara et al., 1982; Takahara et al., 1983). 
These enzymes belong to the family of hydrolases, those acting on carbon-nitrogen bonds 
other than peptide bonds, specifically in linear amidines.  
Protein deimination has been demonstrated to be implicated in several skin physiological 
and pathological processes in human. PADs have long been suspected to be responsible for 
protein citrullination in the epidermis, as well as in some skin appendages, and their 
biological roles to be important. Thereby, there is an increasing interest about PAD research 
in dermatology and biomedicine. However, the molecular mechanisms controlling their 
expression and activity in human skin are still not fully understood. 
In this chapter, we review PAD gene family, the regulation of their expression in 
keratinocytes, their known skin substrates, their physiological roles in the epidermis and 
skin appendages, and their associations with skin diseases. It is anticipated that these 
investigations will provide novel therapeutic and prophylactic targets for future approaches 
to the treatment or prevention of severe psoriasis and other skin diseases. 
Peptidylarginine deiminases (PAD) hydrolyze arginine residues within proteins to create 
the non-native amino acid citrulline (see Figure 1, next page). Calcium ion is essential for the 
enzyme activation. Enzymatic deimination abolishes positive charges of native protein 
molecules, inevitably causing significant alterations in their structures and functions.  
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Fig. 1. Schematic representation of the deimination reaction catalyzed by a peptidylarginine 
deiminase.  
2. Peptidylarginine deiminase family 
Recently, vertebrate PADs were categorized into five isotypes, named PAD type I (PAD1), 
type II (PAD2), type III (PAD3), type IV (PAD4), and type VI (PAD6), based on their amino 
acid sequences, substrate specificities and tissue location (Chavanas et al., 2004; Méchin et 
al., 2005; Nachat et al., 2005a, 2005b). PAD4 has been previously designated as PAD5 
(Vossenaar et al., 2003). Three isotypes are known in birds (Gallus gallus), whereas only one 
seems to exist in amphibians (Xenopus laevis) and fish (Danio rerio, Takifugu rubripes, 
Tetraodon nigroviris, and Oncorhynchus mykiss) (Vossenaar et al., 2003; Ying et al., 2009; Rebl 
et al., 2010). In mammals, all five isotypes of PADs have definitely been found in mouse 
(Mus musculus), rat (Rattus norvegicus) and human (Homo sapiens) (Terakawa, et al., 1991; 
Vossenaar et al., 2003). The five mammalian PADs are highly conserved at the amino acid 
sequence level with 59-71% of homology between human paralogs (45-55% identity). In 
addition, the genes (named PADI) encoding each mammalian PAD type are clustered on 
single chromosomal locus, and they display the same exon/intron structure and a high 
nucleotide sequence homology in exons.  
In human, all PADI genes are located at a single cluster which spans an about 334.7 kb 
region on the short arm of Chromosome 1 near the telomere (1p36.1). Conservation has been 
demonstrated at the levels of nucleotide sequences and organization of the human and 
murine PADI gene loci (Chavanas et al., 2004; Balandraud et al. 2005). Human PADs are 
proteins of 74.1-77.7 kDa predicted molecular mass (663-694 amino acids) with a rather 
acidic pI (4.97-6.15). Human PAD1 is mainly found in the epidermis and hair follicles. This 
isotype is involved in the late stages of epidermal differentiation. In corneocytes, it 
deiminates filaggrin and keratin K1, which maintains hydration of the stratum corneum, 
and hence the epidermal barrier function. This enzyme may also play a role in hair follicle 
formation (Chavanas et al., 2006). Human PAD2 enzyme is the most widely expressed 
family member (Ishigami et al., 2002, 2005). In particular, PAD2 is the only one among PAD 
isotypes to be expressed at a high level in central nervous system. Myelin basic protein, glial 
fibrillary acidic protein and vimentin are its known substrates. PAD2 is thought to play a 
role in the onset and progression of neurodegenerative human disorders, including 
Alzheimer disease and multiple sclerosis, and it has also been implicated in glaucoma 
pathogenesis (Bhattacharya et al., 2006; Moscarello et al., 2007; Cafaro et al., 2010). Human 
PAD3 modulates hair follicle structural proteins, such as trichohyalin and S100A3 in the 
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inner root sheath (Rogers et al., 1997; Kanno et al., 2000; Kizawa et al., 2008). Together with 
the PAD1 enzyme, PAD3 may also play a role in terminal differentiation of the epidermis 
(Senshu et al., 1996; Méchin et al., 2007). Human PAD4 was first identified from the myeloid 
leukaemia cell line, HL-60 (Nakashima et al., 1999). It is normally found in the nucleus and 
in cytoplasmic granules of eosinophils and neutrophils. It has been reported to be involved 
in granulocyte and macrophage development leading to inflammation and the immune 
response (Wang et al., 2004). PAD4 is also expressed in rheumatoid arthritis synovial tissues 
(Vossenaar et al., 2003; Foulquier et al., 2007). Moreover, PAD4 is important for epigenetics, 
since the deimination of arginines and/or monomethylated arginines on histones 3 and 4 
can act to antagonise arginine methylation (Kouzarides, 2007). Human PAD6, also known as 
ePad in mouse, was first identified in the year of 2004 (Chavanas et al., 2004). PAD6 mRNAs 
have been detected in ovary, testis, peripheral blood leucocytes, oocytes and early cleavage 
stage embryos (Chavanas et al., 2004; Esposito, et al., 2007; Yurttas, et al., 2008). However, 
the detail functions of PAD6/ePad are not well-known yet, even if it is essential for mouse 
fertility. Indeed, its absence induces an early zygote/embryo developmental defect 
(Esposito et al., 2007). 
3. Expression of peptidylarginine deiminases in human skin 
Although all PADI genes share significant identities at the level of their coding nucleotide 
sequences, the mechanisms responsible for their patterns of expression have been suspected 
to diverge. As described in section 2, each PADI gene has its own specific pattern of 
expression depending on the considered tissue, cell type or differentiation stage of the cells. 
Among the human PADs, only PAD1, PAD2 and PAD3 are expressed in the skin (Kanno et 
al., 2000; Ishigami et al., 2002; Guerrin et al., 2003). Here, we will sum up the actual findings 
on PAD expression in the human epidermis and skin appendages. 
3.1 Peptidylarginine deiminases in the epidermis 
Using RT-PCR experiments we have shown that only three PAD genes are expressed in 
human skin and epidermis at the mRNA level, namely the PADI1, 2 and 3 genes (Kanno et al., 
2000; Ishigami et al., 2002; Guerrin et al., 2003). Messenger RNAs encoding PAD 4 and 6 are 
not detected in the normal tissue. Using anti-peptide antibodies specific for each isoform, we 
have confirmed this result at the protein level (Nachat et al., 2005a; Chavanas et al., 2006). 
Moreover, PAD1 is localized in the cytoplasm of keratinocytes throughout the whole human 
epidermis, with a higher expression in the granular layer, and in the corneocytes. PAD2 has 
been detected in the cytoplasm of the spinous keratinocytes and at the periphery of the 
granular ones, with a more intense staining of the latter. Anti-PAD3 antibodies have produced 
a punctate staining in the cytosol of the granular keratinocytes. PAD3 has also been observed 
in the matrix of the lower corneocytes, colocated with filaggrin, but could not be detected 
beyond the third or fourth corneocyte layer. Immunoelectron microscopy analyses have been 
used to specify the location at the ultrastructural level: PAD1 and PAD3 are located in the 
keratohyalin granules, together with profilaggrin, and in the fibrous matrix of the corneocytes 
together with filaggrin. PAD1 is also associated with the keratin intermediate filaments in the 
granular cells. Immunoblottings carried out on samples obtained from the superficial horny 
layer using adhesive tape stripping, confirmed that only PAD1 persists in the upper 
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corneocytes, where keratins K1 and K10 are deiminated. Based on their biochemical properties 
and location within the fibrous matrix of the lower corneocytes, we have proposed PAD1 and 
PAD3 as the isoforms responsible for the deimination of filaggrin (Méchin et al., 2005; Nachat 
et al., 2005a; Chavanas et al., 2006). Therefore, PAD1 and 3 may participate in, and possibly 
control, the production of the amino acid components of the Natural Moisturizing Factor 
(NMF). In the upper cornified layer, the NH2- and COOH-termini of keratins K1 and K10 are 
deiminated by PAD1 since it is the only PAD isoform detected there. In agreement, PAD1 is 
less sensitive than the other isoforms to a pH of 5.2, closed to the acidic pH of the upper 
stratum corneum (Méchin et al., 2007). The effect of keratin deimination is not really known, 
but it is concomitant with and therefore could be involved in the modifications of the 
intracorneocyte fibrous matrix observed at the ultrastructural level. In addition, PAD1 and/or 
PAD3 could be involved in the deimination of filaggrin-2, a recently described protein of the 
S100-fused type protein family that may participate in the formation of the NMF (Hsu et al, 
2011). The epidermal targets and the function of PAD2 in the epidermis have not been 
identified so far.  
3.2 Peptidylarginine deiminases in skin appendages 
We have also been able to localize PADs in human skin appendages using the same specific 
antibodies (Nachat et al., 2005b). PAD1 has been observed, together with PAD2, in the 
secretory and myoepithelial cells of the sweat glands, and in the arrector pili muscles (Nachat 
et al., 2005b; Urano, et al.; 1990). However, no deiminated proteins have been detected in these 
appendages. For the moment, the role of PADs in cells of sweat glands and arrector muscles is 
completely unknown. So far, no PADs have been detected in human sebaceous glands. 
PADs have also been detected in hair follicles in the anagen stage. PAD1 is expressed in the 
cytoplasm of keratinocytes in the concentric epithelial sheaths forming the hair follicles: first 
(starting from the hair bulb) the cuticle of the inner root sheath, then the Huxley’s layer of 
the inner root sheath and finally the companion layer between the inner and the outer root 
sheaths. PAD3 is present within the inner root sheath and the medulla of the hair follicles. 
PAD3 has been shown to be perfectly colocalized with trichohyalin, which is the first 
protein shown to be deiminated. Trichohyalin is a major structural protein of cells in the 
inner root sheath and in the medulla of the hair shaft. Moreover, in vitro deimination by 
PAD3 of this alpha-helix-rich insoluble protein makes it more soluble and renders it 
available for efficient cross-linking by transglutaminase 3 (Tarca et al., 1997; Kanno et al., 
2000). This strongly suggests that in vivo deimination by PAD3 allows trichohyalin to be 
solubilized from cytoplasmic granules where it is aggregated and then to be associated with 
hair keratins and other cornified cell components through covalent cross-links carried out 
by transglutaminases. Interestingly, some of these hair keratins, namely the inner root 
sheath-specific type-I keratin 27 and its mouse ortholog, are also deiminated before being 
cross-linked (Steinert et al., 2003). Therefore, PAD3 plays a major role in the establishment of 
the mechanical resistance of cells in the hair follicles and particularly in the hair shaft. PAD3 
is also colocalized with S100A3, a calcium-binding protein of the S100 protein family 
supposed to be involved in hair cell differentiation. In vitro deimination by PAD3 of S100A3 
at the Arg-51 promotes the assembly of a homotetramer, and increases its affinity for 
calcium ions (Kizawa et al., 2008).  
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4. Regulation of peptidylarginine deiminase expression in keratinocytes 
As the specific expression and distribution of PADs in human epidermis and skin 
appendages became clear, it appeared another question “how is the PAD gene expression 
controlled?” In fact, the PADI gene locus represents an interesting model to study the 
mechanisms which direct the spatial and temporal expression of genes in the epidermis. 
Indeed PADI gene expression is accurately regulated during the keratinocyte differentiation 
steps. PAD1 is detected throughout the epidermis with an increased expression in 
differentiated cells, PAD2 in the suprabasal layers, and PAD3 only in the terminally 
differentiated keratinocytes. Therefore PAD expression clearly depends upon the 
keratinocyte differentiation state. Until 2010, several original papers, shown in Figure 2 for a 
chronologic study, were published by our groups on PADI gene regulations at the 
transcriptional level.  
These publications support the hypothesis of multiple DNA/transcription factor chromatin 
modules regulating PAD expression in normal human epidermal keratinocytes (NHEK), at 
the transcriptional level through a complex and original mechanism. The following sections 
will review what is known about the transcriptional regulation of PADI1-3 expression, 
remark the multiple regulatory modules, and highlight their significant features. 
 
Fig. 2. History of transcriptional regulation of PADI1-3 
Until 2010, the promoters of PADI1, 2 and 3, including the transcriptional factors and their 
binding sites, have been identified (Dong et al., 2005; Dong et al., 2006; Dong et al., 2008). 
Moreover, conserved non-coding sequences (CNSs) have been found in the PADI gene 
locus. They have been shown to contribute to long-distance transcriptional regulations of 
PADI1 and PADI3 promoters. One is an intronic enhancer located in the first intron of 
PADI1. Driven by NF-κB, it is able to enhance the PADI1 promoter activity (Ying et al., 
2010). The other one located between PADI2 and PADI3 regulates PADI3 transcription by a 
long-range chromatin looping (86-kb) during keratinocyte differentiation (Chavanas et al., 
2008; Adoue et al., 2008). See detail in the text. Note that the scale is not respected. 
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4.1 Basal regulation of proximal promoters  
Proximal promoter elements are required for basal expression of all PADI1, 2 and 3 genes. 
The characterization of the PADI1-3 promoters has revealed several cis-elements for a 
number of distinct transcription factors. In the case of PADI1, chromatin 
immunoprecipitation (ChIP) assays have demonstrated that MZF1 and Sp1/Sp3 bind to its 
promoter region in vivo. Furthermore, either MZF1 or Sp1, but not Sp3, small interfering 
RNAs have effectively diminished the PADI1 expression in NHEK cultured in both low- 
and high-calcium containing medium (Dong et al., 2008). In addition, it also has been found 
that the expression of MZF1 and PAD1 increases synchronously during epidermal 
keratinocyte differentiation in vivo. Probably, MZF1 acts as an activator of the basic 
transcriptional activity, in response to the extracellular Ca2+ signaling cascades that lead to 
PADI1 expression during cell early differentiation (Dong et al., 2008). Although it lacks 
canonical TATA and CAAT boxes, the minimal promoter region of PADI2 contains some 
typical eukaryotic promoter elements, including four canonical GC boxes. Electrophoretic 
mobility-shift assays and super-shift analyses have demonstrated that both Sp1 and Sp3 
actually bind to the GC boxes, and shown their marked involvement in the transcription 
regulation of PADI2. PADI3 proximal promoter has two CCAAT boxes, two GC boxes and a 
typical TATA box (Dong et al., 2005, 2006). Electrophoretic mobility-shift and ChIP assays 
have revealed that nuclear factor Y (NF-Y) present in keratinocyte nuclear extracts actually 
bind the two CCAAT boxes, while Sp1/Sp3 bind the two GC boxes both in vitro and in vivo. 
Either deletion or site-directed mutagenesis of one of the CCAAT or GC boxes dramatically 
decreases the promoter activity (Dong et al., 2006). Furthermore, Sp1 or NF-YA (one of the 
three subunits of NF-Y) small interfering RNAs effectively diminish PADI3 gene expression 
in NHEK cultured in both low- and high-calcium medium. Therefore, both Sp1 and NF-Y 
are necessary for the expression of PADI3. 
In the transcriptional regulation of PADI1, 2 and 3 in NHEK, Sp1/Sp3 is a common basic 
transcriptional factor. Sp-family of ubiquitous transcription activators is known to regulate 
the constitutive expression of a considerable number of genes, and to take part in virtually 
all aspects of cellular functions, including proliferation, apoptosis and differentiation 
(Kaczynski et al., 2003). Our results suggest that the ratio of Sp1 and Sp3 factors bound to 
the promoter of PADI genes is responsible for the basal regulation of PAD1-3 in the upper 
keratinocyte layers of the epidermis (Ying et al., 2009).  
4.2 Enhancer activity of conserved non-coding sequences 
Eukaryotic gene transcription is controlled not only by promoters but also by intragenic cis-
elements. More recently, a number of CNSs in vertebrate genomes have been shown to be 
transcriptional regulatory regions (Adams, 2005; Pennacchio, et al., 2006). Curiously, some 
highly conserved cis-regulatory regions are preferentially linked to developmental 
regulatory genes such as transcription factors and certain cell communication signals 
(Strähle & Rastegar, 2008). Regarding to PADI genes, nineteen CNSs are clustered in an 8-kb 
region between PADI1 and PADI2. Interestingly, this region shows remarkable sequence 
conservation between several species, further suggesting its functional relevance (Chavanas 
et al, 2004). Subsequently, this region has been shown to contain a calcium responsive 
enhancer called CNS2 or PIE (for PAD intergenic enhancer segment), which dramatically 
triggers the activity of the PADI3 gene promoter upon epidermal keratinocyte 
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differentiation, and links PADI3 expression to the AP-1 transcription factors c-Jun and JunD 
(Chavanas et al., 2008; Adoue et al., 2008). AP1 and Sp families have been suggested to play 
a central role in the regulation of epidermal gene expression during keratinocyte 
differentiation. 
Moreover, except PADI6 gene, each of the human PADI genes contains a long first intron 
(10-23 kb), suggesting the first introns of these PADI genes are conserved during the 
speciation. In past, it has generally been assumed that the introns correspond to junk DNA 
without any function. More recently, however, this was disputed: more and more evidences 
revealed that introns are involved in transcriptional regulation and other functions (Eckert 
and Welter, 1996; Eckert et al., 1997). In particular, in silico analysis identified a conserved 
putative enhancer region within the first intron of PADI1. This region contains several 
consensus binding motifs for transcription factors, such as NF-κB, ELK1 and CREL. 
Furthermore, ChIP results provided powerful evidence that both p50 and p65 NF-κB 
subunits directly bind to a cis-element (named CNSi) identified within the first intron of the 
PADI1 gene, and are critical for the in vivo expression of this gene via transcriptional 
regulatory mechanisms (Ying et al., 2010). 
4.3 Regulatory mechanism by an intra-chromatin loop  
Of great interest, chromosome conformation capture (3C) technique recently testified that 
distant enhancers co-localize and thus that chromatin has necessary to form loops to put 
them in contact within the nucleus (Dekker et al., 2002, 2006). The 3C technique has 
confirmed that the enhancer CNS2 described above, is physically close to the PADI3 gene 
promoter, thanks to a chromatin loop formation. Indeed, as shown in Figure 2, the enhancer 
is located 86 kb away from the PADI3 promoter (Chavanas et al., 2008; Adoue et al., 2008). 
Afterwards, 3C has also provided conclusive evidence for a potential interaction between 
the intronic CNSi, including the NF-κB cis-element, and the PADI1 gene promoter by way of 
chromatin looping (Ying et al., 2010). Long-range cis-elements are recently known as 
important regulators of gene transcription, particularly for paralogous genes clustered on a 
unique chromosomal region (for examples, see Ying et al., 2010). Such a contact between 
chromatin regions in calcium-stimulated keratinocytes suggests that intra-chromatin 
loopings govern the specific expression of PADI1 and 3 genes in a dynamic and united 
mechanism. Since long-range enhancers have been identified in a variety of other 
chromosomal regions distant from their cognate promoters and shown to be functional in 
keratinocytes (Carter et al. 2002; Li et al., 2002; Fraser, 2006; Bartkuhn et al., 2008), such a  
gene regulation at a distance might be a key feature in keratinocytes. These 
intrachromosomal chromatin loops constitute an important element in the architecture of 
the nucleus and in the regulatory control of a number of genes. 
4.4 Other modules 
Calcium ion has long been suspected as a major regulator of PADI genes at the 
transcriptional level. Similarly to the increased detection of PAD1-3 in the epidermis in the 
course of differentiation (Ying et al., 2009), the expression of PADI1-3 mRNAs is enhanced 
about two fold in NHEK cultured in 1.2 mM calcium (differentiating conditions) as 
compared to 0.15 mM (proliferating conditions). Local calcium ion concentrations could also 
regulate the subcellular localization of PADs, and their activity (Ying et al., 2009). In 
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addition, high NHEK density increases PAD1 (threefold) and 3 (fivefold), but not PAD2, at 
the mRNA and protein levels, and up-regulates protein deimination (Méchin et al., 2010). By 
contrast, vitamin D increases PAD1–3 mRNA amounts, with distinct kinetics, but neither the 
corresponding enzymes nor the deimination rate (Méchin et al., 2010). 
5. Peptidylarginine deiminases in skin physiology and diseases 
As well-known, the skin provides a mechanical protection and is an important barrier for 
preventing the invasion of pathogens, the unintentional entrance of exogenous substances, 
and the uncontrolled loss of water and solutes (Madison, 2003). More and more evidence 
indicate that protein deimination and PADs are involved in several epidermal physiological 
and pathological processes. Thus, the identification of the targets of PADs is considered 
critical for advancing research on skin physiology and diseases. 
5.1 Deimination and peptidylarginine deiminases in skin physiology 
In human skin, all known substrates of PADs are cytoskeletal and cytoskeleton-associated 
proteins, crucial components for human skin homeostasis involved in forming rigid 
structures and keeping moisturizing of the horny layer. It has been found that filaggrin, 
filaggrin-2, keratin 1 (K1) and keratin 10 (K10) in the epidermis (Senshu et al., 1996; Kamata 
et al., 2009; Hsu et al, 2011), as well as trichohyalin and S100A3 in the hair follicles are the 
major deiminated proteins (Rogers et al., 1997; Tarcsa et al., 1996, 1997). The presence of 
deiminated proteins mainly in the stratum corneum suggests a function for deimination 
during cornification, the last steps of terminal differentiation of keratinocytes. 
Deimination of filaggrin is a critical step in the production of a pool of amino acids 
necessary for the epidermal barrier functions (Kamata et al., 2009). Filaggrin is one of 
structural basic proteins found in abundance in the epidermis, and produced by the 
keratinocytes for organizing the keratin matrix. Filaggrin is synthesized by keratinocytes of 
the granular layer as a large precursor (400 kDa in human) called profilaggrin, an essential 
component of type F keratohyalin granules. During the granular keratinocyte to corneocyte 
transition, profilaggrin is proteolysed into filaggrin units. These histidine- and arginine-rich 
units associate with the keratin intermediate filaments facilitating their aggregation and the 
resulting formation of the intracorneocyte fibrous matrix. After its deimination in the 
stratum corneum, each filaggrin unit is thought to dissociate from the matrix and to be fully 
proteolysed to generate free amino acids of the NMF, a complex mixture of osmotic agents 
essential to maintain 10–15% water in the stratum corneum (Rawlings & Matts, 2005; 
Méchin et al., 2007; Kamata et al., 2009). The NMF is composed of glycerol, urea, lactate, ions 
and free amino acids (52%), of which two derivatives have been characterized: pyrrolidone 
carboxylic acid and trans-urocanic acid. The amino acid content of NMF are nearly all 
produced from the degradation of filaggrin, their relative proportion being closely related to 
the filaggrin composition (Méchin et al., 2007; Simon et al., 2008; Kamata et al., 2009).  
However, filaggrin-2 degradation is strongly suspected to participate to the NMF formation 
(Hsu et al., 2011). Deimination of both filaggrin and filaggrin-2 increases the rate of their 
degradation by calpain 1 ad bleomycin hydrolases (Kamata et al., 20009; Hsu et al., 2011). 
Recently, non-sense mutations of the filaggrin gene have been defined as very strong pre-
disposing factors for atopic dermatitis (OMIM 603165) and causative factors of ichtyosis 
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vulgaris (OMIM 146700) (Irvine & McLean, 2006; Palmer et al., 2006; Smith et al., 2006; 
Nomura et al., 2007; Sandilands et al., 2007). We have demonstrated the capacity of purified 
recombinant PADs to deiminate human filaggrin in vitro with different calcium and pH 
sensitivities according to the isotype of the used enzymes. These differences could regulate 
filaggrin deimination in vivo as calcium- and pH-gradients are known to exist in the stratum 
corneum (Méchin et al., 2005, 2007). The exact role of keratin deimination is not well known. 
We can suspect an effect on the structure of the intracorneocyte filamentous matrix, or on 
their partial proteolysis in the upper part of the stratum corneum.  
As mentioned in Section 3.2, trichohyalin is a structural protein of cells in the inner root sheath 
and in the medulla of the hair shaft. The deimination of trichohyalin catalyzed by PAD3 is 
crucial for the properties of trichohyalin, as well as for S100A3, another major protein of the 
hair follicles (Tarcsa et al., 1996, 1997; Steinert et al., 2003; Kizawa et al., 2008). Thereby, PAD3 
is likely to play a major role in the establishment of the mechanical resistance of cells in the 
hair follicles and particularly in the hair shaft. However, the exact function of PAD1 and PAD2 
in the hair follicles, including their targeted proteins, remains unknown.  
5.2 Deimination and peptidylarginine deiminases in skin diseases 
In recent years, more and more evidences suggested that the deimination and PADs are 
associated with skin diseases, especially with psoriasis. For example, decreased levels of 
keratin, in particular K1, deimination were observed in the epidermis of patients with 
bullous congenital ichthyosiform erythroderma (OMIM 113800) and psoriasis (OMIM 
177900) (Ishida-Yamamoto, et al., 2000, 2002). Moreover, the PAD inhibitor paclitaxel, a well 
known molecule for cancer therapy, has been shown to improve severe psoriasis in a 
prospective phase II pilot study (Ehrlich et al., 2004). Furthermore, since vitamin D is 
beneficial in the treatment of psoriasis (Durakovic et al., 2004), it is tempting to speculate 
that the three PADs (PAD1, 2 and 3) expressed in the epidermis are possible therapeutic 
targets in the disease. 
Interestingly, it is also thought that PADs might be involved in skin cancer. Indeed, PAD4 is 
abnormally expressed in some cutaneous cancers, as skin malignant melanoma (Chang et 
al., 2006, 2009). Especially, expression of PAD4 has been observed in some malignant tumors 
including skin carcinomas, with a concominant increased in deiminated keratins, and in 
extramammary Paget's disease (OMIM#167300) (Urano et al., 1990; Chang et al., 2006, 2009). 
PAD4 expression is not detected in the corresponding human normal tissues. In agreement 
with the hypothesis of a possible involvement of PADs in tumorigenesis, inhibition or 
depletion, in osteosarcoma U2OS cells, of PAD4, the isotype responsible for the deimination 
of histones and involved in gene-expression regulation, has recently been shown to result in 
cell cycle arrest and apoptosis (Li, et al., 2008). So, PAD4 is becoming a target for an 
epigenetic cancer therapy (Slack et al., 2011). As a new finding, differential expression of the 
PADI1 gene has been claimed as a hallmark of squamous cell carcinomas of the oral cavity 
and oropharynx (Chen et al., 2008).  
6. Conclusion 
Nowadays, PADs are more and more considered as important in cellular physiology and 
human diseases. Over-expression of PAD and accumulation of citrullinated proteins could 
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have a negative role. As we know, citrulline produced by PADs is a “non-natural” amino 
acid. Thereby, citrulline may stimulate the immune system and induce immune responses. 
More and more reports claim that citrullinated autoantigens are the possible cause of several 
autoimmune inflammatory diseases, including neurodegenerative disorders (multiple 
sclerosis and Alzheimer disease) and rheumatoid arthritis. Indeed, the current knowledge 
attests that multiple sclerosis is strongly linked to overcitrullination of the myelin basic 
protein (reviewed in Méchin et al., 2007). As another similar example, the patients with 
Alzheimer’s disease have significantly elevated rate of citrullination (vimentin and glial 
fibrillary acidic protein) in their central nervous system, mainly in the hippocampus, which 
is the region of the brain mostly affected by the disease (Ishigami et al., 2005). Therefore 
PADs are now taken as potential drug targets.  
Because of the description of their involvement in the late steps of keratinocyte terminal 
differentiation and the stratum corneum barrier functions, dermatologists are expected to 
take a great interest in these enzymes. In future, some approaches should provide new 
insight into PADI gene regulatory networks and discover the elaborate mechanisms of their 
signalling pathways upon cell dynamic state. More work is of great significance to 
definitively conclude on their contribution to skin diseases, especially in psoriasis and other 
inflammatory disorders. 
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